Factors That Influence Changes in Mammographic Density With Postmenopausal Hormone Therapy

Taiwanese Journal of Obstetrics and Gynecology

Volumn 49, Issue 4, 2010, Pages 413-418

  Chen, Fang Ping ^a   Cheung, Yun Chung ^a   Soong, Yung Kui ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Estrogen; Estrogen progestin; Hormone therapy; Mammographic density; Postmenopausal women

Indexed keywords

CONJUGATED ESTROGEN; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; MEDROXYPROGESTERONE ACETATE; PROGESTERONE;

ADULT; AGED; ARTICLE; BODY MASS; BREAST DENSITY; CELL DENSITY; CONTROLLED STUDY; DISEASE ASSOCIATION; ESTROGEN THERAPY; FEMALE; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MENOPAUSAL SYNDROME; ONSET AGE; POSTMENOPAUSE; PROGESTERONE THERAPY; RETROSPECTIVE STUDY; TREATMENT DURATION;

ADULT; AGE FACTORS; AGED; BODY MASS INDEX; BREAST; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; MAMMOGRAPHY; MENOPAUSE; MIDDLE AGED; PROGESTINS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 78650751954     PISSN: 10284559     EISSN: 10284559     Source Type: Journal    
DOI: 10.1016/S1028-4559(10)60091-5     Document Type: Article

References (42)

1. Boyd NF, Dite GS, Stone J, et al. Heritability of mammographic density, a risk factor for breast cancer. N Engl J Med 2002, 347:886-894.
2. Pankow JS, Vachon CM, Kuni CC, et al. Genetic analysis of mammographic breast density in adult women: evidence of a gene effect. J Natl Cancer Inst 1997, 89:549-556.
3. El-Bastawissi AY, White E, Mandelson MT, Taplin SH Reproductive and hormonal factors associated with mammographic breast density by age (United states). Cancer Causes Control 2000, 11:955-963.
4. Sterns EE, Zee B Mammographic density changes in perimenopausal and postmenopausal women: is effect of hormone replacement therapy predictable?. Breast Cancer Res Treat 2000, 59:125-132.
5. Van Gils CH, Hendriks JH, Otten JD, Holland R, Verbeek AL Parity and mammographic breast density in relation to breast cancer risk: indication of interaction. Eur J Cancer Prev 2000, 9:105-111.
6. Vachon CM, Kuni CC, Anderson K, Anderson VE, Sellers TA Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States). Cancer Causes Control 2000, 11:653-662.
7. Sala E, Warren R, Duffy S, Welch A, Luben R, Day N High risk mammographic parenchymal patterns and diet: a case-control study. Br J Cancer 2000, 83:121-126.
8. Greendale GA, Reboussin BA, Sie A, et al. Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators. Ann Intern Med 1999, 130:262-269.
9. Boyd NF, Byng JW, Jong RA, et al. Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst 1995, 87:670-675.
10. Byrne C, Schairer C, Wolfe J, et al. Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst 1995, 87:1622-1629.
11. Writing Group for the Women's Health Initiative Investigators Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the women's health initiative randomized controlled trial. JAMA 2002, 288:321-333.
12. Laya MB, Gallagher JC, Schreiman JS, Larson EB, Watson P, Weinstein L Effect of postmenopausal hormone replacement therapy on mammographic density and parenchymal pattern. Radiology 1995, 196:433-437.
13. Leung W, Goldberg F, Zee B, Sterns E Mammographic density in women on postmenopausal hormone replacement therapy. Surgery 1997, 122:669-673.
14. D'Orsi CJ, Bassett LW, Feig SA, the American College of Radiology BI-RADS™ Committee, et al. Illustrated Breast Imaging Reporting and Data System 1998, American College of Radiology, Reston, Va. 3rd ed.
15. Vachon CM, Kushi LH, Cerhan JR, Juni CC, Sellers TA Association of diet and mammographic breast density in the Minnesota breast cancer family cohort. Cancer Epidemiol Biomarkers Prev 2000, 9:151-160.
16. Gapstur SM, Lopez P, Colangelo LA, Wolfman J, Van Horn L, Hendrick RE Associations of breast cancer risk factors with breast density in Hispanic women. Cancer Epidemiol Biomarkers Prev 2003, 12:1074-1080.
17. Roubidoux MA, Kaur JS, Griffith KA, et al. Correlates of mammogram density in southwestern native-American Women. Cancer Epidemiol Biomarkers Prev 2003, 12:552-558.
18. Rutter CM, Mandelson MT, Laya MB, Seger DJ, Taplin S Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. J Am Med Assoc 2001, 285:171-176.
19. Lundström E, Wilczek B, von Palffy Z, Soderqvist G, von Schoultz B Mammographic breast density during hormone replacement therapy: differences according to treatment. Am J Obestet Gynecol 1999, 181:348-352.
20. Heng D, Gao F, Jong R, et al. Risk factors for breast cancer associated with mammographic features in Singaporean Chinese Women. Cancer Epidemiol Biomarkers Prev 2004, 13:1751-1758.
21. Newcomb PA, Titus-Ernstoff L, Egan KM, et al. Post-menopausal estrogen and progestin use in relation to breast cancer risk. Cancer Epidemiol Biomarkers Prev 2002, 11:593-600.
22. Magnusson C, Baron JA, Correia N, Bergstrom R, Adami HO, Persson I Breast-cancer risk following long-term oestrogen- and oestrogen-progestin replacement therapy. Int J Cancer 1999, 81:339-344.
23. Colditz GA, Hankinson SE, Hunter DJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995, 332:1589-1593.
24. Titus-Ernstoff L, Tosteson ANA, Kasales C, Weiss J, Goodrich M, Hatch EE, Carney PA Breast cancer risk factors in relation to breast density (United States). Cancer Causes Control 2006, 17:1281-1290.
25. Sala E, Warren R, McCann J, Duffy S, Luben R, Day N High-risk mammographic parenchymal patterns, hormone replacement therapy and other risk factors: a case-control study. Int J Epidemiol 2000, 29:629-636.
26. Boyd NE, Lockwood GA, Little LE, Yaffe MJ, Tritchler DL The relationship between anthropometric measures to radiological features of the breast in premenopausal women. Br J Cancer 1998, 78:1233-1238.
27. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 1997, 350:1047-1059. Collaborative Group on Hormonal Factors in Breast Cancer.
28. Chen CL, Weiss NS, Newcomb P, Barlow W, White E Hormone replacement therapy in relation to breast cancer. J Am Med Assoc 2002, 287:734-741.
29. Scharirer C, Lubin J, Triosi R, Sturgeon S, Brinton L, Hoover R Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. J Am Med Assoc 2000, 283:485-491.
30. Brinton LA, Hoover RN, Szklo M, Fraumeni JF Menopausal estrogen use and risk and risk of breast cancer. Cancer 1981, 47:2517-2522.
31. Van den Brandt P, Dirx MjM, Ronckers CM, van den Hoogen P, Goldbohm AR Height, weight, weight change, and postmenopausal breast cancer risk: the Netherlands Cohort Study. Cancer Causes Control 1997, 8:39-47.
32. Brinton LA, Hoover R, Fraumeni JF Menopausal oestrogens and breast cancer risk: an expanded case-control study. Br J Cancer 1986, 54:825-832.
33. Chen FP, Cheung YC, Teng LF, Soong YK The Relationship between mammographic density and duration of hormone therapy: effects of estrogen and estrogen-progestin. Human Reproduction 2005, 20:1741-1745.
34. Baines CJ, Vidmar V, McKeown-Eyssen G, Tibshirani R Impact of menstrual phase on false-negative mammograms in the Canadian National Breast Screening Study. Cancer 1997, 80:720-724.
35. White E, velentgas P, Mandelson MT, et al. Variation in mammographic breast density by time in menstrual cycle among women aged 40-49 years. J Natl Cancer Inst 1998, 90:906-910.
36. Ursin G, Parisky YR, Pike MC, Spicer DV Mammographic density changes during the menstrual cycle. Cancer Epidemiol Biomarkers Prev 2001, 10:141-142.
37. Cline JM, Söderqvist G, von Schoultz B, Skoog L, von Schoultz E Effect of hormone replacement therapy on the mammary gland of surgically postmenopausal cynomolgus macaques. Am J Obstet Gynecol 1996, 174:93-100.
38. Stomper PC, Van Voorhis BJ, Ravnikar VA, Meryer JE Mammographic changes associated with postmenopausal hormone replacement therapy: a longitudinal study. Radiology 1990, 174:487-490.
39. Persson I, Thurfjell E, Holmber L Effect of estrogen and estrogen-progestin replacement regimens on mammographic breast parenchymal density. J Clin Oncol 1997, 15:3201-3207.
40. Marugg RG, van der Mooren MJ, Hendriks JH, Rolland R, Ruijs SH Mammographic changes in postmenopausal women on hormonal replacement therapy. Eur Radiol 1997, 7:749-755.
41. Sendag F, Terek MC, Özsener S, et al. Mammographic density changes during different postmenopausal hormone replacement therapies. Fertil Steril 2001, 76:445-450.
42. Gram IT, Bremnes Y, Ursin G, Maskarinec G, Bjurstam N, Lund E Percentage density, Wolfe's and Tabár's mammographic patterns: agreement and association with risk factors for breast cancer. Breast Cancer Res 2005, 7:R854-R861.